BRCA1 and triple-negative breast carcinoma: Analyses of the Ku-DBi sensitivity were performed in the BRCA1 mutant triple-negative breast cancer (TNBC) cell line MDA-MB-436 and the BRCA1 wild-type MDA-MB-468.